Search results
New weight loss drugs are coming, and they could burn more fat with fewer side effects
NBC News via Yahoo News· 2 days agoThere aren’t just GLP-1 drugs in the pipeline. On Thursday, ahead of the diabetes conference,...
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Reuters· 4 days agoAmylyx Pharmaceuticals has agreed to buy the rights to bankrupt drugmaker Eiger BioPharmaceuticals' ...
New drug’s potentially fatal side effects obscured by ‘soothing acronym,’ doctors say
The Columbian· 2 days agoSeventy-nine-year-old Genevieve Lane volunteered to take the Alzheimer’s drug Leqembi in a clinical trial because she was forgetting words and misplacing her keys. Infusions ...
Argenx Surges After Its Bread-And-Butter Drug Wins Another FDA Approval
Investor's Business Daily· 1 day agoChico noted 99% of patients in the Adhere test also enrolled in an open-label extension study. In an...
Wave, with new data, plots path forward for Huntington’s drug
BioPharma Dive via Yahoo Finance· 9 hours agoThe company plans to make a case to regulators for a new accelerated approval pathway. But investors...
Jazz Pharmaceuticals' tremor drug fails in mid-stage study
Reuters via Yahoo News· 5 days ago(Reuters) -Jazz Pharmaceuticals said on Thursday its experimental drug to treat a common movement disorder failed to reduce tremor severity in a mid-stage ...
New weight loss drugs are on the way — and the health benefits are even more promising
The Independent via Yahoo News· 1 day agoAltimmune expects to begin a phase three trial soon. The company hopes the drug will be available in...
Merck KGgA shares slide after failure of potential head and neck cancer drug
Investing.com via Yahoo Finance· 15 hours agoInvesting.com -- Shares in Merck KGaA (ETR:MRCG) slumped by more than 10% on Tuesday after the drugmaker announced that it had discontinued a Phase III study evaluating its treatment for patients with head and neck cancer.
Zealand Offers $900 Million in Shares to Fund New Obesity Drugs
Bloomberg via Yahoo Finance· 4 hours ago(Bloomberg) -- Zealand Pharma A/S is selling about 6.3 billion Danish kroner ($900 million) in new...
Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead
Motley Fool via Yahoo Finance· 4 days agoThis deal will add povetacicept to Vertex's portfolio. The experimental drug has shown promise in...